VYOME HOLDINGS, INC. Increase (Decrease) in Due to Affiliates
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Due to Affiliates of -$25.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToAffiliates · last filed 2026-08-12
- VYOME HOLDINGS, INC. increase (decrease) in due to affiliates for the quarter ending 2026-06-30 was -$8.00, a 100.03% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in due to affiliates for the quarter ending 2026-03-31 was -$25.22K, a 324.92% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in due to affiliates for the quarter ending 2025-12-31 was $19.94K, a 36.73% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in due to affiliates for the quarter ending 2025-09-30 was $14.52K, a 0.46% increase year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in due to affiliates for fiscal 2025 was $75.22K, a 21.63% decline from fiscal 2024.
- VYOME HOLDINGS, INC. increase (decrease) in due to affiliates for fiscal 2024 was $95.97K.
| Period end | Increase (Decrease) in Due to Affiliates 3 month | Increase (Decrease) in Due to Affiliates 6 month | Increase (Decrease) in Due to Affiliates 6 month as first filed | Increase (Decrease) in Due to Affiliates 9 month | Increase (Decrease) in Due to Affiliates 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$8.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$25.22K 10-Q · filed 2026-08-12 | -$5.28K derived: sum of 3 quarters · filed 2026-08-12 | $9.24K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | -$25.22K 10-Q · filed 2026-05-12 | -$5.28K derived: sum of 2 quarters · filed 2026-05-12 | $9.25K derived: sum of 3 quarters · filed 2026-05-12 | $38.79K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | $19.94K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $34.46K derived: sum of 2 quarters · filed 2026-03-18 | $64.00K derived: sum of 3 quarters · filed 2026-08-12 | $75.22K 10-K · filed 2026-03-18 | |
| 2025-09-30 | $14.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $44.06K derived: sum of 2 quarters · filed 2026-08-12 | $55.27K 10-Q · filed 2025-11-14 | $86.79K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $29.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $40.75K 10-Q · filed 2026-08-12 | $50.00K 8-K · filed 2025-09-02 | $72.27K derived: sum of 3 quarters · filed 2026-08-12 | $86.72K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $11.21K 10-Q · filed 2026-05-12 | $42.73K derived: sum of 2 quarters · filed 2026-05-12 | $57.18K derived: sum of 3 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $31.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $45.97K derived: sum of 2 quarters · filed 2026-03-18 | $95.97K 10-K · filed 2026-03-18 | ||
| 2024-09-30 | $14.46K derived: 10-Q 9 month − 8-K 6 month · filed 2025-11-14 | $64.46K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $50.00K 8-K · filed 2025-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |